Research associated with Risk communication

Publications:

Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence.
Zikmund-Fisher BJ, Fagerlin A, Roberts TR, Derry HA, Ubel PA. Journal of Health Communication. 13(2):107-124, 2008.

"If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits.
Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Patient Education and Counseling. 69:140-144, 2007.

Does labeling prenatal screening test results as negative or positive affect a woman's responses?
Zikmund-Fisher BJ, Fagerlin A, Keeton K, Ubel PA. American Journal of Obstetrics and Gynecology. 197:528.e1-528.e6, 2007.

Validation of the subjective numeracy scale (SNS): Effects of low numeracy on comprehension of risk communications and utility elicitations.
Zikmund-Fisher BJ, Smith DM, Ubel PA, Fagerlin A. Medical Decision Making. 27:663-671, 2007.

Mortality versus survival graphs: Improving temporal consistency in perceptions of treatment effectiveness.
Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Patient Education and Counseling. 66:100-107, 2007.

Can avoidance of complications lead to biased healthcare decisions?
Amsterlaw J, Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Judgment and Decision Making. 1:64-75, 2006.

A matter of perspective: choosing for others differs from choosing for yourself in making treatment decisions.
Zikmund-Fisher BJ, Fagerlin A, Sarr B, Ubel PA. Journal of General Internal Medicine. 21:618-622, 2006.

Individualized survival curves improve satisfaction with cancer risk management: decisions in women with BRCA 1/2 mutations.
Armstrong K, Weber B, Ubel PA, Peters N, Holmes J, Schwartz JS. Journal of Clinical Oncology. 23:9319-9328, 2005.

Cure me even if it kills me: Preferences for invasive treatment.
Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Medical Decision Making. 25:614-619, 2005.

Reducing the influence of anecdotal reasoning on people's health care decisions: Is a picture worth a thousand statistics?
Fagerlin A, Wang C, Ubel PA. Medical Decision Making. 25:398-405, 2005.

How making a risk estimate can change the feel of that risk: Shifting attitudes toward breast cancer risk in a general public survey.
Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Patient Education and Counseling. 57:294-299, 2005.

Is 28% good or bad?: Evaluability and preference reversals in health care decisions.
Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Medical Decision Making. 24:142-148, 2004.

Measuring numeracy without a math test: development of the subjective numeracy scale (SNS).
Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM. Medical Decision Making. 27:672-680, 2007.

Assessing and communicating risks and benefits of gene transfer clinical studies.
Kim S. Current Opinion in Molecular Therapeutics. 8:384-389, 2006.

Do clinicians follow a risk-sensitive model of capacity determination? An experimental video survey.
Kim S, Caine ED, Swan JG, Appelbaum PS. Psychosomatics . 47:325-329, 2006.

What is the risk of sham surgery in Parkinson's disease clinical trials? A review of published reports.
Frank S, Kieburtz K, Holloway RG, Kim S. Neurology. 65:1101-1103, 2005.

What's time got to do with it? Inattention to duration in interpretation of survival graphs.
Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Risk Analysis. 25:589-595, 2005.

Press Coverage:

No information found.